2014
DOI: 10.1097/spc.0000000000000068
|View full text |Cite
|
Sign up to set email alerts
|

Noninvasive ventilation as a palliative measure

Abstract: NIV is an important adjunct to medications for patients with intractable dyspnea. Future research should attempt to clarify the effectiveness of NIV at controlling dyspnea within and outside the hospital. Barriers to its domiciliary application are largely unknown. Processes should be developed to optimize communication among clinicians, patients, and their caregivers around the issues of when to start NIV and how to withdraw it at the end of life.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
10
0
2

Year Published

2015
2015
2023
2023

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 26 publications
(13 citation statements)
references
References 73 publications
1
10
0
2
Order By: Relevance
“…Moreover, in the recent years, intensive care medicine has progressed considerably, and new technologies continuously improve ventilatory treatment and survival [87]. In the case of risk of acute-on-chronic RF, appropriate education of caregivers and periodic followup are necessary to optimize domiciliary assistance and to remove barriers to its application [88,89].…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, in the recent years, intensive care medicine has progressed considerably, and new technologies continuously improve ventilatory treatment and survival [87]. In the case of risk of acute-on-chronic RF, appropriate education of caregivers and periodic followup are necessary to optimize domiciliary assistance and to remove barriers to its application [88,89].…”
Section: Discussionmentioning
confidence: 99%
“…Non-invasive ventilation offers an option but remains unusual in palliative care because it remains difficult to identify patients who will benefit from this technique, and this option remains controversial in patients who have elected specific limits to life support [81,82]. Thoracocentesis, chemical or talc pleurodesis, and minimally invasive palliative treatment options such as chronic IPCs may all be helpful in cases of pleural effusion.…”
Section: Continuedmentioning
confidence: 99%
“…Since the mismatch between ventilatory demand and ventilatory capacity is critical to the sensation of dyspnoea, non‐invasive ventilatory support would seem to offer a potential therapy for the relief of dyspnoea in patients with fibrotic lung disease. There is evidence that this approach is valuable in patients with respiratory muscle weakness and in patients with COPD during exercise . In a study of 10 IPF patients, the use of proportional assist ventilation (PAV—similar to bi‐level positive pressure ventilation) on a cycle ergometer cardiopulmonary exercise test increased exercise tolerance and reduced dyspnoea during the test.…”
Section: Common Symptoms Experienced By Patients With Iipmentioning
confidence: 99%